Work

Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab, Rituximab, and PGG Beta Glucan: A Phase I Clinical Trial

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.1792.1792

Authors: Clive S. Zent, Betsy R. LaPlant, Timothy G. Call, Deborah A. Bowen, Michael J. Conte, Wei Ding, George J. Weiner, Thomas E. Witzig

Institutions: Mayo Clinic, University of Iowa, University of Iowa Holden Comprehensive Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2549697291

FWCI: 0.152

Cites:

Cited by: 1

Related to: 10